Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration–Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics
2018 ◽
Vol 57
(10)
◽
pp. 1307-1323
◽
2013 ◽
Vol 41
(4)
◽
pp. 744-753
◽
2020 ◽
Vol 17
(7)
◽
pp. 2329-2344
◽
2012 ◽
Vol 101
(11)
◽
pp. 4277-4292
◽
2020 ◽
Vol 109
(7)
◽
pp. 2345-2355
1999 ◽
Vol 11
(4)
◽
pp. 309-315
◽
2006 ◽
Vol 308
(1-2)
◽
pp. 133-139
◽